Primrose Bio Awarded NIH Grant to Develop Genetic Medicine Drug Design Technology
$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO, July 15, 2026 /PRNewswire/ -- Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month...
$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO, July 15, 2026 /PRNewswire/ -- Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.